VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 84 filers reported holding VOYAGER THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.44 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $178 | -29.6% | 23,025 | +4.1% | 0.00% | – |
| Q2 2023 | $253 | +178.0% | 22,126 | +86.5% | 0.00% | – |
| Q1 2023 | $91 | +85.7% | 11,866 | +46.7% | 0.00% | – |
| Q4 2022 | $49 | -99.9% | 8,091 | -21.3% | 0.00% | – |
| Q3 2022 | $60,000 | 0.0% | 10,283 | 0.0% | 0.00% | – |
| Q2 2022 | $60,000 | -55.2% | 10,283 | -41.8% | 0.00% | – |
| Q1 2022 | $134,000 | +605.3% | 17,678 | +144.7% | 0.00% | – |
| Q4 2021 | $19,000 | +26.7% | 7,223 | +21.0% | 0.00% | – |
| Q3 2021 | $15,000 | -58.3% | 5,970 | -33.2% | 0.00% | – |
| Q2 2021 | $36,000 | – | 8,940 | +4922.5% | 0.00% | – |
| Q1 2021 | $0 | -100.0% | 178 | -98.5% | 0.00% | – |
| Q4 2020 | $86,000 | +473.3% | 12,102 | +1225.5% | 0.00% | – |
| Q3 2019 | $15,000 | -96.9% | 913 | -96.4% | 0.00% | -100.0% |
| Q1 2018 | $482,000 | +44.3% | 25,658 | +27.2% | 0.00% | 0.0% |
| Q4 2017 | $334,000 | – | 20,179 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 3,851,507 | $29,849,179 | 1.01% |
| ARMISTICE CAPITAL, LLC | 4,178,000 | $32,379,500 | 0.50% |
| SummerHaven Investment Management, LLC | 72,779 | $564,037 | 0.41% |
| GLOBEFLEX CAPITAL L P | 453,595 | $3,515,361 | 0.41% |
| Ikarian Capital, LLC | 305,857 | $2,370,392 | 0.28% |
| Hillsdale Investment Management Inc. | 367,590 | $2,848,824 | 0.26% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 103,966 | $805,737 | 0.24% |
| Parkman Healthcare Partners LLC | 60,322 | $467,496 | 0.09% |
| Inspire Investing, LLC | 82,656 | $640,584 | 0.08% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 52,500 | $406,875 | 0.08% |